Key result
Percutaneous ASD closure significantly decreased indexed right atrial volume from 39 to 20 ml/m2 at 6 months (P<0.001), despite an early worsening of electrocardiographic predictors of arrhythmias.
Why the study?
Does percutaneous ASD closure improve atrial electrogeometric remodelling in asymptomatic patients with large ASD?
Observational (n=15)
Does percutaneous ASD closure improve atrial electrogeometric remodelling in asymptomatic patients with large ASD?
Absolute Event Rate: 20% vs 39%
p-value: p=<0.001
Percutaneous ASD closure induces positive volumetric remodelling but may transiently worsen electrocardiographic arrhythmia predictors, warranting close early follow-up.
Associated with favorable right atrial remodeling; extends observational data but leaves arrhythmia risk implications open for prospective study.
BACKGROUND: Atrial arrhythmias are well known long-term complications of atrial septal defect (ASD), presumably due to chronic atrial enlargement and stretch. Surgical repair often fails to revert the arrhythmic risk despite atrial volumetric unloading, maybe as a consequence of atriotomic scar. Avoiding atrial incision, percutaneous ASD closure should result in atrial unloading and arrhythmic risk decrease. This study evaluated the atrial short-term electrogeometric effects of percutaneous ASD closure. METHODS: Fifteen asymptomatic patients (age 23 +/- 5 years) submitted to percutaneous closure of large ASD (QP/QS 2.4 +/- 0.3) using the Amplatzer Septal Occluder device (24 +/- 2 mm) underwent atrial echocardiographic (indexed right atrial size and left atrial size as well as right atrial/left atrial volume ratio) and electrocardiographic (P-wave duration and dispersion, PR conduction time and dispersion) evaluation at 1 and 6 months after ASD closure. RESULTS: After 6 months, the indexed right atrial volume and the right atrial/left atrial volume ratio had significantly decreased (from 39 +/- 5 to 20 +/- 2 ml/m2, P < 0.001 and from 2.0 +/- 0.2 to 1.0 +/- 0.1, P < 0.0001, respectively) as did the P-wave dispersion (from 32 +/- 2 to 28 +/- 1 ms, P = 0.03) despite a significant increase of both P-wave maximal (from 75 +/- 3 to 81 +/- 3 ms, P < 0.01) and minimal (from 42 +/- 3 to 53 +/- 3 ms, P < 0.005) duration. CONCLUSION: Percutaneous ASD closure causes a short-term positive atrial electrogeometric remodelling. The electrocardiographic predictors of atrial arrhythmias, however, tend to worsen early after device implantation despite a marked volumetric unloading, possibly due to a 'foreign body' effect of the occluding device. This might warrant a closer follow-up during the first few weeks after device implantation.
No takes yet. Share an insight, caveat, or question.
Santoro et al. (2008) conducted an observational in atrial septal defect (n=15). Percutaneous ASD closure vs. Baseline was evaluated on Indexed right atrial volume (ml/m2) (p=<0.001). Percutaneous ASD closure significantly decreased indexed right atrial volume from 39 to 20 ml/m2 at 6 months (P<0.001), despite an early worsening of electrocardiographic predictors of arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: